Antidotehealth
Antidotehealth7About
What does Antidotehealth do?
Antidote Health is a digital healthcare provider that leverages artificial intelligence to deliver affordable, 24/7 virtual primary care, urgent care, mental health services, and chronic condition management. The platform aims to democratize healthcare access for uninsured and underinsured individuals and families across the United States.
Is Antidotehealth trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Antidotehealth is 26 out of 100, based on site security posture and privacy practices.
When was Antidotehealth founded?
Antidotehealth was founded in 2026.
What industry does Antidotehealth operate in?
Antidotehealth operates in Telemedicine, HealthTech, MedTech, Digital Twin Healthcare, Mental Health Tech, AI Infrastructure.
What is Antidotehealth's current status?
Antidotehealth's current operating status is: Inactive.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
Provides Applied Behavior Analysis (ABA) Therapy and related services for children and adolescents in the Greater Seattle area.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
Improving NHS appointment access with a user-friendly digital solution.
AI-powered platform connecting users with ancestral health knowledge and practitioners.
Docsynapse provides verified doctors a secure space to discuss patient cases with an integrated AI clinical assistant.
AI-powered platform modernizing senior and behavioral health facilities with smart infrastructure and clinical intelligence.
An entrant is a company tagged Telemedicine whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.